Member Info for SteveV

So this presentation is to "....focus on providing further background on the Company's operations and growth strategy, as updated in the announcement on 22 June 2021.....

Surely the strategy can NOT be planned or implemented until we know what the outcome of the DHSC dispute.
especially given "....Novacyt remains focused on M&A to supplement these initiatives...."

We could be talking + or - £100m or so depending on the Dispute. That will dramatically affect the sort of acquisition targets
NCYT aim at, which surely will affect the planned growth.

So does this mean we will have news of the before the meeting? Or are they lamely going to say well these are our plans but it kinda depends on what happens !!!

I am guessing, but I think the timing of GM's leaving(retirement) has been quite carefully planned.

He would clearly like to go out on a high(who wouldn't). But the buck for the DHSC debacle had to stop with him, which I think will ultimately end with a positive resolution sometime before he goes. (The new guy would surely not want to be the one have to deal with the outcome of something disastrous...would anyone want to take that on?)

The second phase of the DHSC contract(the potential game changer) isn't going to happen quite as anticipated. As such there isn't going to be a £800m or so CASH bonanza to splash out on lucrative acquisitions to EASILY drive the business forward to mid cap status. (which was GM's plan)

The business is still however VERY sound and generating lots of revenue, but the growth will now be as a result of a concerted sales and marketing drive. A new man at the helm was needed for this. Either GM didn't think he was the man for the job, or just didn't have the inclination, OR, the rest of the board thought they needed some new blood who was better placed to drive the business forward given the current circumstances. We know from GM's RNS's sales and marketing are NOT his expertise.
Will the new CEO change this?, will he get us listed on a US market?, will he take us to Midcap status?
Hmm...hope so.

Although the new CEO won't want to see a huge rise in sp until he has started and gets his bonus arrangements set up.!!

I would imagine if they were going to release an update then decided not to it may be because we are close something
material re: the DHSC dispute one way or the other. As has been mentioned we kinda know what the other figures are likely to be.

Simply Wall street is a completely inaccurate pointless website.
AVOID for any meaningful information.

Hey Deedo, NCYT are a not a health care provider. They develop world class tests and sell them to health care providers.

Your ignorant rant is very unwelcome.

Hey Johnny, NCYT have always maintained that they haven't failed on any part of their contract.
There is a lot of money outstanding and it will have to be sorted out at some point.
We have heard nothing yet of this being escalated to legal action and have to assume that a resolution is under way in arbitration.

I personally think the incompetent DHSC is simply playing for time. The bill will be paid when they need more product.

If NCYT tell us that the DHSC dispute is nearing a positive resolution, AND, currently sales are strong, AND they expect that to continue into next year, THEN we can expect a BIG re rate.

I am very hopeful all of the above will happen.

100 Million unvaccinated in the USA. Cases up 46% in the last week as Delta variant takes hold there.

NCYT must surely be as busy as they have ever been. Money must be rolling in.

In 2020 investors were discussing how long the COVID revenue stream would last. A lot us thought at the time
2021 may/would drop off a cliff as things thankfully would get back to normal. NO, that didn't happen and in fact when compared to last summer when things had gone quiet it is shocking how bad things are this summer. What is winter 2021 going to be like? !!!!

The DHSC dispute will resolve at some point. I imagine the DHSC are rather cynically dragging things out until a point in time it benefits them most, because they can.

Sp will move very quickly up soon IMO

Yes, that will be the trade of 8 shares...(yes 8 shares !!)

When I said LSE is more accurate that Google at closing prices I didn't mean the London Stock Exchange
I meant London South East ........https://www.lse.co.uk/

Trust me I have seen it many many times

You can't trust google closing prices they are very often wrong.

They seem to often take a slightly after hours trade and base the closing sp on that.
If you look at the trades there is one(only) at 16.36 at 356p..........for 8 shares !!!

LSE, I find, is much more accurate at closing prices. Google is rubbish! (at closing prices)

Hey Poidster, that is big news "....NHS labs running of of Promate now too apparently..."

Who is running out exactly? Individual NHS hospitals who are using the Q machines. Surely they can reorder supplies direct under the NHS new framework.
Or is it NHS central testing labs. Do they even use Q machines and Promate?

Hey, earth, and Mr Big,

India ARE really quite poor per Capita.
https://www.worldometers.info/gdp/gdp-per-capita/

Unfortunately some countries, especially with VERY large populations as compared to GDP just can't afford to pay for the level of testing and vaccination that UK do.

The NCYT RNS regarding the new Antigen products did say they are initially targeting the private sector.

"...Paris, France and Camberley, UK - 29 June 2021 - Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in clinical diagnostics, is to launch two PathFlow® COVID-19 antigen lateral flow tests (LFTs) to strengthen the Company's COVID-19 portfolio and to pursue significant new market opportunities, especially in point-of-care (POC) settings. The Company will initially target private market opportunities for these LFTs via its existing distribution network...."

I think most have been surprised by the rapid growth of the Delta variant in the UK in MID-SUMMER

No one predicted we would be where we are today.

BUT if you think about it the Delta variant was first diagnosed and spread rapidly in India.

COVID seems very able to mutate so that it can thrive in various climates.(It is clearly NOT necessarily seasonal)

I hope I'm wrong but I can imagine that we get over the Delta variant this summer only to find that a NEW WINTER variant emerges.

Excellent time for NCYT to release the home use LFT test. RNS tomorrow would be great!!!

If NCYT want to remain FIRM with the DHSC but maintain a good relationship in lieu of new business, they could
say " Sure, yes we can replace the out of date stock you thought you didn't want - at cost price of £20m. BUT you will have to pay the £20m. !!....Now what other products do you want to buy, get in quick because we have big demand from other countries and private test centres"

https://blogs.bmj.com/bmj/2021/07/11/why-all-the-secrecy-around-innova-lateral-flow-tests/